What the federal election means for entitlements, regulations and immigration
By
Lois A. Bowers
Sep 24, 2024
Regardless of who wins the presidential election, senior living providers should not expect big changes any time soon regarding so-called entitlement programs such as Medicare, Medicaid and Social Security;...
Prevalence of homebound 22 percent in national Medicare Advantage plan
Aug 12, 2024
Homebound status linked to increased odds of ED visit, inpatient admission, skilled nursing-facility admission, mortality
Dual proposals aim to redesign ‘patchwork’ of LTSS delivery for dual-eligible recipients
By
Kimberly Bonvissuto
May 29, 2024
Redesigning the nation’s patchwork approach to delivering long-term services and supports to dually eligible individuals is the goal behind two proposals.
Assisted living mental health services fell between 2019 and 2020, study finds
By
Kristen Fischer
Apr 25, 2024
Mental health visits for assisted living residents living with dementia dropped as the pandemic set in, a new study finds.
‘Landmark legislation’ aims to streamline, coordinate care for 12 million dually eligible individuals
By
Kimberly Bonvissuto
Mar 21, 2024
A bipartisan bill aiming to streamline and coordinate care for the nation’s more than 12 million dually eligible individuals — people who are enrolled in both Medicare and Medicaid — is being called...
Senior living can be a partner in delivering, improving care, CMS official says
By
Lois A. Bowers
Mar 07, 2024
Even though senior living providers, by law, are unable to directly bill the Medicare program for the services they provide to residents, they are able to partner with other organizations focused on value-based...
A variety of models can help CCRC operators meet residents’ increasing healthcare needs
By
Kimberly Bonvissuto
Feb 16, 2024
Older adults are moving into senior living communities with more chronic conditions and healthcare needs than ever before, presenting challenges — as well as opportunities — for continuing care retirement...
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Navigating insurance for those with dementia a major challenge for family caregivers
By
Kathleen Steele Gaivin
Jan 30, 2024
Family caregivers face many challenges in helping their loved ones who are living with dementia, not the least of which is navigating the insurance landscape for long-term care. That’s according to the...
Study maps ‘home time’ for Medicare beneficiaries in assisted living communities
By
Kristen Fischer
Dec 21, 2023
A new study gives more insight into how much time older people in assisted living spend in and out of the setting.